PMC:7361216 / 2956-3240 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T34","span":{"begin":183,"end":189},"obj":"Body_part"},{"id":"T35","span":{"begin":201,"end":213},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma62977"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma62925"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T15","span":{"begin":183,"end":189},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":162,"end":172},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T38","span":{"begin":146,"end":147},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T39","span":{"begin":220,"end":223},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T27","span":{"begin":201,"end":213},"obj":"Chemical"}],"attributes":[{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T24","span":{"begin":201,"end":213},"obj":"Chemical"}],"attributes":[{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T6","span":{"begin":29,"end":37},"obj":"Species"}],"attributes":[{"id":"A6","pred":"ncbi_taxonomy_id","subj":"T6","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T18","span":{"begin":130,"end":145},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-sample-PD-UBERON","denotations":[{"id":"T11","span":{"begin":183,"end":189},"obj":"Body_part"}],"attributes":[{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"71","span":{"begin":29,"end":37},"obj":"Disease"},{"id":"90","span":{"begin":148,"end":172},"obj":"Disease"},{"id":"82","span":{"begin":183,"end":213},"obj":"Gene"},{"id":"85","span":{"begin":215,"end":218},"obj":"Gene"}],"attributes":[{"id":"A71","pred":"pubann:denotes","subj":"71","obj":"MESH:C000657245"},{"id":"A90","pred":"pubann:denotes","subj":"90","obj":"MESH:D003711"},{"id":"A82","pred":"pubann:denotes","subj":"82","obj":"Gene:4099"},{"id":"A85","pred":"pubann:denotes","subj":"85","obj":"Gene:4099"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T34","span":{"begin":183,"end":213},"obj":"Protein"},{"id":"T45","span":{"begin":215,"end":218},"obj":"Protein"}],"attributes":[{"id":"A34","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/Q567S4"},{"id":"A35","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/Q15489"},{"id":"A36","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P20917"},{"id":"A37","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P20916"},{"id":"A38","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P16880"},{"id":"A39","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P07723"},{"id":"A40","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P07722"},{"id":"A41","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/P02685"},{"id":"A42","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/F5GYC0"},{"id":"A43","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/B7Z2E5"},{"id":"A44","pred":"uniprot_id","subj":"T34","obj":"https://www.uniprot.org/uniprot/A0A087WPR1"},{"id":"A45","pred":"uniprot_id","subj":"T45","obj":"https://www.uniprot.org/uniprot/Q567S4"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T34","span":{"begin":183,"end":189},"obj":"Body_part"},{"id":"T35","span":{"begin":201,"end":213},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma62977"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma62925"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T11","span":{"begin":29,"end":37},"obj":"Disease"},{"id":"T12","span":{"begin":162,"end":172},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T2","span":{"begin":148,"end":161},"obj":"Phenotype"},{"id":"T3","span":{"begin":162,"end":172},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0011096"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0009830"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":148,"end":161},"obj":"Phenotype"},{"id":"T3","span":{"begin":162,"end":172},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0011096"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0009830"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-sentences","denotations":[{"id":"T18","span":{"begin":130,"end":145},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}

{"project":"LitCovid-PubTator","denotations":[{"id":"71","span":{"begin":29,"end":37},"obj":"Disease"},{"id":"82","span":{"begin":183,"end":213},"obj":"Gene"},{"id":"85","span":{"begin":215,"end":218},"obj":"Gene"},{"id":"90","span":{"begin":148,"end":172},"obj":"Disease"}],"attributes":[{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:C000657245"},{"id":"A82","pred":"tao:has_database_id","subj":"82","obj":"Gene:4099"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"Gene:4099"},{"id":"A90","pred":"tao:has_database_id","subj":"90","obj":"MESH:D003711"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e receptor‐binding domain of CoViD‐19, which might inhibit viral adhesion to its receptor and thus lead the way toward vaccines.\n\n1 INTRODUCTION\nA demyelinating neuropathy targeting myelin‐associated glycoprotein (MAG) has an incidence of approximately one per 100,000 (Mygland \u0026 Mon"}